Please use this identifier to cite or link to this item: https://ahro.austin.org.au/austinjspui/handle/1/26853
Full metadata record
DC FieldValueLanguage
dc.contributor.authorTrubiano, Jason-
dc.contributor.authorMarhoon, Nada-
dc.contributor.authorVogrin, Sara-
dc.contributor.authorChua, Kyra Y L-
dc.contributor.authorHolmes, Natasha E-
dc.date2020-11-17-
dc.date.accessioned2021-06-28T06:12:36Z-
dc.date.available2021-06-28T06:12:36Z-
dc.date.issued2020-11-17-
dc.identifier.citationAntimicrobial Agents and Chemotherapy 2020; 64(12): e01823-20en
dc.identifier.urihttps://ahro.austin.org.au/austinjspui/handle/1/26853-
dc.description.abstractWhereas the short-term impacts of antibiotic allergy testing on delabeling and antibiotic usage have been demonstrated, the long-term impacts have been less well defined. In a single-center matched case-control study from Melbourne, Australia, we demonstrate that a beta-lactam antibiotic allergy testing program has a significant impact on antibiotic usage and infection-related outcomes. This study supports implementation of an antibiotic allergy testing program as a standard of care of antimicrobial stewardship programs.en
dc.language.isoeng-
dc.subjectadverse drug effectsen
dc.subjectallergyen
dc.subjectallergy testingen
dc.subjectantibiotic allergyen
dc.subjectantimicrobial allergyen
dc.subjectantimicrobial resistanceen
dc.subjectantimicrobial stewardshipen
dc.subjectbeta-lactam allergyen
dc.subjectbeta-lactamsen
dc.subjectpenicillin allergyen
dc.titleMatched Case-Control Study of the Long-Term Impact of Beta-Lactam Antibiotic Allergy Testing.en
dc.typeJournal Articleen
dc.identifier.journaltitleAntimicrobial Agents and Chemotherapyen
dc.identifier.affiliationCentre for Antibiotic Allergy and Researchen
dc.identifier.affiliationCentre for Integrated Critical Care, University of Melbourne, Melbourne, Australiaen
dc.identifier.affiliationThe National Centre for Infections in Cancer, Peter MacCallum Cancer Centre, Melbourne, Australiaen
dc.identifier.affiliationMedicine (University of Melbourne)en
dc.identifier.affiliationData Analytics Research and Evaluation (DARE) Centreen
dc.identifier.affiliationDepartment of Medicine (St. Vincent's Hospital), University of Melbourne, Melbourne, Australiaen
dc.identifier.affiliationInfectious Diseasesen
dc.identifier.doi10.1128/AAC.01823-20en
dc.type.contentTexten
dc.identifier.orcid0000-0002-5111-6367en
dc.identifier.pubmedid32988819-
local.name.researcherChua, Kyra Y L-
item.languageiso639-1en-
item.fulltextNo Fulltext-
item.grantfulltextnone-
item.openairecristypehttp://purl.org/coar/resource_type/c_18cf-
item.cerifentitytypePublications-
item.openairetypeJournal Article-
crisitem.author.deptInfectious Diseases-
crisitem.author.deptMedicine (University of Melbourne)-
crisitem.author.deptCentre for Antibiotic Allergy and Research-
crisitem.author.deptIntensive Care-
crisitem.author.deptData Analytics Research and Evaluation (DARE) Centre-
crisitem.author.deptMicrobiology-
crisitem.author.deptInfectious Diseases-
crisitem.author.deptInfectious Diseases-
crisitem.author.deptData Analytics Research and Evaluation (DARE) Centre-
Appears in Collections:Journal articles
Show simple item record

Page view(s)

54
checked on Dec 24, 2024

Google ScholarTM

Check


Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.